Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.7100 (3.4%) ($4.7100 - $4.7100) on Wed. Sep. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.68% (three month average) | RSI | 53 | Latest Price | $4.7100(3.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 6.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) SPLV(92%) USO(-34%) UUP(-73%) SDY(82%) SHY(64%) | Factors Impacting ATRA price | ATRA will decline at least -5.34% in a week (0% probabilities). IDRV(91%) HYG(95%) IWC(87%) IWN(90%) BNDX(13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.34% (StdDev 10.68%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.73(-0.42%) | 10 Day Moving Average | $4.52(4.2%) | 20 Day Moving Average | $4.44(6.08%) | To recent high | -46.4% | To recent low | 65% | Market Cap | $350m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |